A S X A N N O U N C E M E N T ASX: CUV | Nasdaq: CUVL | Börse Frankfurt: UR9 Results of Annual General Meeting Melbourne – 6 November 2026 – CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) advises, in accordance with Listing Rule 3.13.2 and section 251AA of the Corporations Act, the...
Results of Meeting
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Clinuvel Pharmaceuticals Limited has announced the results of its Annual General Meeting, detailing the resolutions voted on by shareholders. The filing indicates that all resolutions were decided by way of a poll, with specific results provided for each resolution. Notably, the resolution for the adoption of the remuneration report was not carried, marking a second strike under the Corporations Act. The document also includes information about the re-election of directors and other resolutions presented at the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings CallRelease
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- Chair address - amendment
- Managing Director Address
- Chair address
- CLINUVEL files NEURACTHEL Instant dossier
- Notification of cessation of securities - CUV
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals